Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence in respiratory medicine: From diagnosis to treatment and future directions.

Chinese medical journal pulmonary and critical care medicine·2026
Same author

Artificial intelligence in multimodal data analysis for cancer survival prediction.

Progress in molecular biology and translational science·2026
Same author

Learning to take it personally: Precision drug repurposing through patient-specific loss on knowledge graphs using Biobank data.

Journal of biomedical informatics·2026
Same author

scProfiterole: Clustering of Single-Cell Proteomic Data Using Graph Contrastive Learning via Spectral Filters.

bioRxiv : the preprint server for biology·2026
Same author

What Does Next-Generation Mass Spectrometry Offer for Proteomics? A Comprehensive Platform Comparison.

Journal of proteome research·2026
Same author

Systems Biology and Network Analysis: From Multi-omics Integration to Biological Mechanisms.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

Interpretable machine learning for Parkinson's disease diagnosis, staging, and biological mechanism exploration: a multicenter analysis.

BioData mining·2026
Same journal

Learning a distance for the clustering of patients with amyotrophic lateral sclerosis.

BioData mining·2026
Same journal

Multi-domain feature fusion with variational mode decomposition and hybrid LightGBM-Logistic Regression for multi-class seizure classification.

BioData mining·2026
Same journal

Large-scale transcriptomic data mining using explainable XGBoost and SHAP reveals shared biomarkers and molecular mechanisms between type-2 diabetes and triple-negative breast cancer for drug repurposing.

BioData mining·2026
Same journal

AVSeg-XAI: Deep learning framework for A/V segmentation with vascular features reveals retinal oculomics as biomarker for cardiovascular disease.

BioData mining·2026
Same journal

Navigating the uncharted: AI-driven advances in protein structure, dynamics, interactions and ligand interactions for understudied families.

BioData mining·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

DADA: Degree-Aware Algorithms for Network-Based Disease Gene Prioritization.

Sinan Erten1, Gurkan Bebek, Rob M Ewing

  • 1Department of Electrical Engineering and Computer Science, Case Western Reserve University, Cleveland, OH, USA. sinan.erten@case.edu.

Biodata Mining
|June 25, 2011
PubMed
Summary
This summary is machine-generated.

We developed DADA, a new suite for prioritizing candidate disease genes using protein-protein interaction networks. DADA improves accuracy by statistically adjusting for network biases, outperforming existing methods.

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Related Experiment Videos

Last Updated: May 31, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Area of Science:

  • Bioinformatics
  • Systems Biology
  • Computational Biology

Background:

  • Protein-protein interaction (PPI) networks are crucial for prioritizing disease-associated genes.
  • Existing methods struggle with incomplete and noisy PPI data, often biased towards highly connected genes.
  • Information flow methods partially address these issues by considering indirect interactions.

Purpose of the Study:

  • To address biases in existing gene prioritization methods that favor highly connected genes.
  • To develop statistically adjusted methods for more accurate candidate disease gene identification.
  • To introduce the DADA suite integrating these novel prioritization strategies.

Main Methods:

  • Proposed statistical adjustment methods accounting for gene degree distribution in PPI networks.
  • Utilized PPI networks with confidence scores for interactions.
  • Developed the DADA suite combining existing and adjusted prioritization approaches.

Main Results:

  • The proposed methods identify loosely connected disease genes missed by current approaches.
  • DADA demonstrates superior performance in prioritizing candidate disease genes compared to existing methods.
  • Experimental validation using the OMIM database confirmed DADA's effectiveness.

Conclusions:

  • Accurate statistical models and adjustment methods are vital for network-based disease gene prioritization.
  • DADA offers an improved approach for identifying candidate disease genes.
  • The DADA suite is freely available for research applications.